News
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
22h
MedPage Today on MSNNew Advisor to FDA Chief Pushed Back on COVID PoliciesTracy Beth Høeg, MD, PhD, who was named a special assistant to new FDA Commissioner Marty Makary, MD, MPH, previously opposed ...
6don MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
1don MSN
Former Food and Drug Administration vaccine chief Dr. Peter Marks discussed his efforts to 'make nice' with Kennedy and ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
6don MSN
Tracy Beth Hoeg, a sports medicine physician and epidemiologist who opposed key U.S. health policies during the COVID-19 ...
Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results